Literature DB >> 29859808

Preclinical evaluation of aerosol administration systems using Positron Emission Tomography.

Unai Cossío1, Vanessa Gómez-Vallejo2, María Flores3, Braulio Gañán-Calvo3, Gloria Jurado3, Jordi Llop4.   

Abstract

Pulmonary administration of drugs has recently gained attention because it exhibits numerous advantages compared to oral or intravenous administration. The administration of aerosols for inhalation to animals, however, remains a critical challenge and only a few methods of administration have been developed. Herein, we compare the regional distribution of aerosols in the lungs of wild type rats after pulmonary administration using three different methods: (a) The Penn-Century MicroSprayer® Aerosolizer; (b) an in-house designed aerosol generation system; and (c) the Aeroneb® Lab Micropump Nebulizer. Both the regional distribution and the fraction of aerosol deposited in the lungs were determined by means of radiolabelling of the aerosol followed by in vivo and ex vivo Positron Emission Tomography (PET) imaging and dissection and gamma counting. Endotracheal insufflation using the PennCentury MicroSprayer resulted in >85% of the administered dose accumulated in the lungs, with a non-uniform distribution of the radioactivity in different lobes and a low animal-to-animal reproducibility. Administration using the in-house designed and the Aeroneb nebulizers resulted in a uniform distribution over the lungs, but only a small fraction of the nebulized activity (ca. 0.1%) was deposited in the lungs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aerosol; Lung administration; Nebulization; PET; Positron Emission Tomography

Mesh:

Substances:

Year:  2018        PMID: 29859808     DOI: 10.1016/j.ejpb.2018.05.037

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  3 in total

1.  Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform.

Authors:  Per Gerde; Mattias Nowenwik; Carl-Olof Sjöberg; Ewa Selg
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-10-15       Impact factor: 2.849

2.  Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats.

Authors:  Hessel van der Weide; Unai Cossío; Raquel Gracia; Yvonne M Te Welscher; Marian T Ten Kate; Aart van der Meijden; Marco Marradi; Jeffrey A S Ritsema; Denise M C Vermeulen-de Jongh; Gert Storm; Wil H F Goessens; Iraida Loinaz; Cornelus F van Nostrum; Jordi Llop; John P Hays; Irma A J M Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection.

Authors:  Ana Castro-Balado; Cristina Mondelo-García; Letricia Barbosa-Pereira; Iria Varela-Rey; Ignacio Novo-Veleiro; Néstor Vázquez-Agra; José Ramón Antúnez-López; Enrique José Bandín-Vilar; Raquel Sendón-García; Manuel Busto-Iglesias; Ana Rodríguez-Bernaldo de Quirós; Laura García-Quintanilla; Miguel González-Barcia; Irene Zarra-Ferro; Francisco J Otero-Espinar; David Rey-Bretal; José Ramón Lago-Quinteiro; Luis Valdés-Cuadrado; Carlos Rábade-Castedo; María Carmen Del Río-Garma; Carlos Crespo-Diz; Olga Delgado-Sánchez; Pablo Aguiar; Gema Barbeito-Castiñeiras; María Luisa Pérez Del Molino-Bernal; Rocío Trastoy-Pena; Rossana Passannante; Jordi Llop; Antonio Pose-Reino; Anxo Fernández-Ferreiro
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.